Structured evidence table for Beta Glucan Skin Health Meta-Analysis, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Beta Glucan Skin Health Meta-Analysis | Chronic wounds present a significant challenge to society and have a negative impact on the quality of life and daily activities of patients. | 1 | Marešová P (2026) | A Systematic Review of the Cost-Effectiveness of Interventions for Chronic Wounds. |
| Beta Glucan Skin Health Meta-Analysis | This review aimed to identify the cost-effectiveness of the currently used care alternatives for the treatment of chronic wounds. | 1 | Marešová P (2026) | A Systematic Review of the Cost-Effectiveness of Interventions for Chronic Wounds. |
| Beta Glucan Skin Health Meta-Analysis | Despite major advances in insulin analogs, pumps, and continuous glucose monitoring, many individuals with T1D continue to experience substantial glycemic variability and hypoglycemia risk, supporting the need for adjunctive, physiology-based strategies beyond insulin replacement alone. | 3 | Grammatiki Maria (2026) | Nutritional Interventions in Type 1 Diabetes: Boosting Residual GLP-1 Responses—Is It an Option? |
| Beta Glucan Skin Health Meta-Analysis | Beyond its acute insulinotropic and glucagonostatic actions, GLP-1 has been associated with beta-cell protective effects in preclinical models, including improved beta-cell survival and proliferative signaling, which has fueled interest in incretin-targeted approaches as disease modifiers rather than glucose-lowering tools alone []. | 3 | Grammatiki Maria (2026) | Nutritional Interventions in Type 1 Diabetes: Boosting Residual GLP-1 Responses—Is It an Option? |
| Beta Glucan Skin Health Meta-Analysis | Postprandial GLP-1 levels in T1D are comparable to or slightly reduced compared to healthy controls, with exaggerated glucagon responses persisting despite GLP-1 elevation [,,]. | 3 | Grammatiki Maria (2026) | Nutritional Interventions in Type 1 Diabetes: Boosting Residual GLP-1 Responses—Is It an Option? |
| Beta Glucan Skin Health Meta-Analysis | Type 1 diabetes (T1D) is a chronic autoimmune disease characterized by progressive pancreatic beta-cell destruction, resulting in absolute insulin deficiency and lifelong dependence on exogenous insulin therapy. | 3 | Grammatiki Maria (2026) | Nutritional Interventions in Type 1 Diabetes: Boosting Residual GLP-1 Responses—Is It an Option? |
Source documents